Dr Melissa C Altom, MD | |
106 Commerce Dr, Aurora, MO 65605-6260 | |
(417) 269-2400 | |
(417) 269-2410 |
Full Name | Dr Melissa C Altom |
---|---|
Gender | Female |
Speciality | Family Medicine |
Location | 106 Commerce Dr, Aurora, Missouri |
Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
Identifier | Type | State | Issuer |
---|---|---|---|
1588677991 | NPI | - | NPPES |
204965602 | Medicaid | MO |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207Q00000X | Family Medicine | 112771 (Missouri) | Primary |
Entity Name | Cox-monett Hospital Inc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1942467410 PECOS PAC ID: 0345236667 Enrollment ID: O20040422000710 |
News Archive
Exposure to high levels of ultrafine particles—invisible particles that can reach the smallest air passages in the lungs—may be an important contributor to the risk of coronary heart disease in firefighters, reports a study in the August Journal of Occupational and Environmental Medicine, official publication of the American College of Occupational and Environmental Medicine (ACOEM).
Tau Therapeutics LLC, a pharmaceutical company developing T-type calcium channel inhibitors for the treatment of solid tumors, announced today that it has opened enrollment for a Phase Ib clinical trial with the National Cancer Institute's Adult Brain Tumor Consortium (ABTC) using the company's first product candidate mibefradil.
Counties that banned in-person religious gatherings and those with a greater number of hospitals per capita were associated with a decreased case-fatality rate of COVID-19 during the pandemic's first wave, according to a new University of Michigan study.
Altheus Therapeutics, Inc. announced the USPTO has allowed patent 8,629,127 B2 covering the oral pharmaceutical composition 5-ASA (5-aminosalicylic acid) and NAC (N-acetylcysteine).
During an event with leaders from three U.S. federal agencies and the White House, the executive director of the Merck Childhood Asthma Network, Inc. (MCAN), Dr. Floyd Malveaux, expressed strong support for the government's new coordinated action plan to reduce racial and ethnic asthma disparities. The release of the new report came on the last day of National Asthma Awareness Month.
› Verified 8 days ago
Mailing Address | Practice Location Address |
---|---|
Dr Melissa C Altom, MD Po Box 802843, Kansas City, MO 64180-2843 Ph: (417) 730-6430 | Dr Melissa C Altom, MD 106 Commerce Dr, Aurora, MO 65605-6260 Ph: (417) 269-2400 |
News Archive
Exposure to high levels of ultrafine particles—invisible particles that can reach the smallest air passages in the lungs—may be an important contributor to the risk of coronary heart disease in firefighters, reports a study in the August Journal of Occupational and Environmental Medicine, official publication of the American College of Occupational and Environmental Medicine (ACOEM).
Tau Therapeutics LLC, a pharmaceutical company developing T-type calcium channel inhibitors for the treatment of solid tumors, announced today that it has opened enrollment for a Phase Ib clinical trial with the National Cancer Institute's Adult Brain Tumor Consortium (ABTC) using the company's first product candidate mibefradil.
Counties that banned in-person religious gatherings and those with a greater number of hospitals per capita were associated with a decreased case-fatality rate of COVID-19 during the pandemic's first wave, according to a new University of Michigan study.
Altheus Therapeutics, Inc. announced the USPTO has allowed patent 8,629,127 B2 covering the oral pharmaceutical composition 5-ASA (5-aminosalicylic acid) and NAC (N-acetylcysteine).
During an event with leaders from three U.S. federal agencies and the White House, the executive director of the Merck Childhood Asthma Network, Inc. (MCAN), Dr. Floyd Malveaux, expressed strong support for the government's new coordinated action plan to reduce racial and ethnic asthma disparities. The release of the new report came on the last day of National Asthma Awareness Month.
› Verified 8 days ago
Dr. Lisa Denise Roark, MD Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 106 Commerce Drive, Aurora, MO 65605 Phone: 417-269-2400 Fax: 417-269-2410 | |
Dr. Robert Marcus Causey, Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 550 S Hudson Ave, Aurora, MO 65605 Phone: 417-678-5176 | |
Dr. Christie J. Hurt, DO Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 550 S Hudson Ave, Aurora, MO 65605 Phone: 417-678-5176 Fax: 417-678-0675 | |
Dr. Kenton L. Stringer, MD Family Medicine Medicare: Medicare Enrolled Practice Location: 500 Porter Ave, Aurora, MO 65605 Phone: 417-678-7888 Fax: 417-678-7858 | |
Bradford P Garner, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 550 S Hudson Ave, Aurora, MO 65605 Phone: 417-678-5176 Fax: 417-678-0675 | |
Dr. J-pia Kim Spruill, MD Family Medicine Medicare: Medicare Enrolled Practice Location: 106 Commerce Dr, Aurora, MO 65605 Phone: 417-269-2400 Fax: 417-269-2410 | |
Paul Berry Andelin, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 203 S Washington Ave Ste A, Aurora, MO 65605 Phone: 417-678-4022 Fax: 417-678-4028 |